Skip to main content

Animations

MJFF Publications

7581 - 7590 of 9035 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2013
  • 2014
  • 2012
  • 2012
  • 2010
  • 2014
  • 2012
  • 2014
  • Summary Details
    OPEN
    Title: Novel Green Fluorescent Polyamines to Analyze ATP13A2 and ATP13A3 Activity in the Mammalian Polyamine Transport System
    Journal Name: Biomolecules
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biom13020337
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Lewy Body-like Pathology and Loss of Dopaminergic Neurons in Midbrain Organoids Derived from Familial Parkinson’s Disease Patient
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells12040625
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones
    Journal Name: European Journal of Medicinal Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.ejmech.2013.10.052
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awu179
    Citation Count: 200
  • Summary Details
    OPEN
    Title: GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2012.06.104
    Citation Count: 151
  • Summary Details
    OPEN
    Title: Characterization of TAE684 as a potent LRRK2 kinase inhibitor
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2012.01.084
    Citation Count: 88
  • Summary Details
    OPEN
    Title: Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2010.05.009
    Citation Count: 218
  • Summary Details
    OPEN
    Title: Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.01.010
    Citation Count: 50
  • Summary Details
    OPEN
    Title: Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/hmg/dds431
    Citation Count: 74
  • Summary Details
    OPEN
    Title: Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/hmg/ddu178
    Citation Count: 174
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.